At-Home Monitoring Device Can Predict Crohn's Disease Flares At-Home Monitoring Device Can Predict Crohn's Disease Flares
A device that remotely monitors the sleep patterns, breathing, and gait of people with Crohn ' s disease can identify increased disease activity prior to it being clinically evident, say researchers.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 8, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Crohn's Disease: What It Is, Symptoms & Treatment
MONDAY, May 8, 2023 -- Crohn ’s disease, a type of inflammatory bowel disease, has no cure. But there are many treatments, specific to type, and it is possible to keep the symptoms under control.
A gastroenterologist offers some tips for those... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 8, 2023 Category: General Medicine Source Type: news
Crohn's disease patients left in agony by over-cautious doctors
Charlotte Hartill, a dental nurse from Plymouth, pictured, suffered dramatic weight loss and incredible pain due to her Crohn's disease and thinks surgeons could have treated her sooner. (Source: the Mail online | Health)
Source: the Mail online | Health - May 6, 2023 Category: Consumer Health News Source Type: news
Eating Fruits and Vegetables Cuts Risk for Crohn's Disease Eating Fruits and Vegetables Cuts Risk for Crohn's Disease
A large, prospective study provides data to guide clinicians who treat patients at high risk for Crohn ' s disease.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - May 1, 2023 Category: Primary Care Tags: Gastroenterology News Source Type: news
Adalimumab + Methotrexate Beneficial for Pediatric Crohn Disease
THURSDAY, April 27, 2023 -- For pediatric Crohn disease (PCD) patients, treatment with methotrexate combined with adalimumab, but not infliximab, is associated with a reduction in treatment failure, according to a study published online March 31 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 27, 2023 Category: Pharmaceuticals Source Type: news
Cochrane study finds stool transplants more effective than antibiotics for treating recurring, life-threatening gut infections
A new Cochrane Review has found that, compared with standard antibiotic treatment, stool transplantation can increase the number of people recovering from Clostridioides difficile (C. diff) infection, a condition which causes potentially life-threatening diarrhea. 77 percent of people who received a stool transplant did not experience reinfection within eight weeks, compared to 40 percent of those who received antibiotics alone.C. diff is a bacterium that can cause life-threatening diarrheal illness in individuals with an unhealthy mixture of gut bacteria, known as dysbiosis. The most common cause of dysbiosis is treatment...
Source: Cochrane News and Events - April 24, 2023 Category: Information Technology Authors: Muriah Umoquit Source Type: news
PET/MRE improves detection of Crohn's disease
Simultaneous PET/MR enterography (MRE) can improve the detection of active inflammator...Read more on AuntMinnie.comRelated Reading:
MRI radiomics identifies subtypes of inflammatory bowel disease
Cinematic rendering complements CT in diagnosing colitis
PET tracer may aid diagnosis of inflammatory bowel disease
10 top tips on best use of MR enterography in small bowel
PET/MR enterography offers potential in Crohn's disease (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 21, 2023 Category: Radiology Source Type: news
Man's condition leaves him unable to have coffee 'without the hell storm of cramps' after
James Wilson was diagnosed with Crohn's disease after years of toilet issues. (Source: Daily Express - Health)
Source: Daily Express - Health - April 17, 2023 Category: Consumer Health News Source Type: news
Merck to acquire Prometheus Biosciences for $10.8B
Shares of Prometheus Biosciences soared 70% in premarket trading on Monday after Merck & Co. announced that it would acquire the company in a $10.8 billion deal. All the shares of Prometheus Biosciences will be acquired by a subsidiary of Merck for $200 per share. The acquisition is subject to…#merckco #merck #prometheus #robertdavis #keytruda #sandiego #crohn #imagobiosciences (Source: Reuters: Health)
Source: Reuters: Health - April 17, 2023 Category: Consumer Health News Source Type: news
Merck to buy Prometheus Biosciences for about $11 billion
Merck & Co (MRK.N) said on Sunday it will buy Prometheus Biosciences Inc (RXDX.O) for about $10.8 billion, picking up a promising experimental treatment for ulcerative colitis and Crohn's disease and building up its presence in immunology. Merck will pay $200 per share for the California-based…#merckco #crohn #merck #robertdavis #pra023 #phaseii #keytruda #acceleron #prometheus #seageninc (Source: Reuters: Health)
Source: Reuters: Health - April 17, 2023 Category: Consumer Health News Source Type: news
Merck to acquire Prometheus Biosciences for $10.8B
Merck & Co. is acquiring Prometheus Biosciences in a $10.8 billion deal. All the shares of Prometheus Biosciences will be acquired by a subsidiary of Merck for $200 per share.. The deal gives Merck promising immune disease treatments. The acquisition is subject to Prometheus Biosciences…#merckco #merck #prometheus #robertmdavis #keytruda #sandiego #crohn #imagobiosciences (Source: Reuters: Health)
Source: Reuters: Health - April 16, 2023 Category: Consumer Health News Source Type: news
Merck in talks to acquire Prometheus Biosciences: report
Merck & Co. is reportedly in talks to acquire Prometheus Biosciences Inc. The talks are said to be in the late stage with a deal possibly announced as soon as Sunday, according to The Wall Street Journal. A deal is not certain and could still fall apart. The deal could give Merck promising immune…#merckco #merck #keytruda #sandiego #crohn #imagobiosciences (Source: Reuters: Health)
Source: Reuters: Health - April 16, 2023 Category: Consumer Health News Source Type: news
Pediatric Crohn's: Adalimumab+Methotrexate Offers Strong Benefit Pediatric Crohn's: Adalimumab+Methotrexate Offers Strong Benefit
A landmark trial suggests adding low-dose methotrexate should be strongly considered in children with Crohn ' s disease who are starting adalimumab.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 14, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
How to Get Better Sleep When You Have IBD
A lot of people with inflammatory bowel disease (IBD) have trouble sleeping. By some estimates, roughly 75% of people with IBD experience sleep disturbances such as trouble falling asleep, trouble staying asleep, and poor overall sleep quality. Meanwhile, surveys of IBD patients have found that poor sleep tends to be the top contributor to quality-of-life issues.
The fact that so many people with IBD experience problems sleeping is bad news for a number of reasons. For one thing, a lot seems to go wrong with the human mind and body when sleep is inadequate; sleep disorders such as insomnia are strongly linked to an increas...
Source: TIME: Health - April 11, 2023 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Gut health healthscienceclimate Source Type: news
